NCT04227977View on ClinicalTrials.gov

Volume Optimization Incorporating Negative Pressure Diuresis in Heart Failure (VOID-HF)

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 12, 2020

Primary Completion Date

May 1, 2023

Study Completion Date

October 20, 2023

Conditions
Cardiorenal Syndrome
Interventions
DEVICE

JuxtaFlow System

The JuxtaFlow System consists of proprietary ureteral catheters deployed endoscopically over the wire to deliver mild controlled negative pressure into the renal pelvis.

Trial Locations (4)

23507

Sentara Norfolk General Hospital, Norfolk

32611

University of Florida, Gainesville

44195

Cleveland Clinic, Cleveland

78229

Univ. of Texas Health, San Antonio

Sponsors

Lead Sponsor

3ive Labs
All Listed Sponsors
lead

3ive Labs

INDUSTRY

NCT04227977 - Volume Optimization Incorporating Negative Pressure Diuresis in Heart Failure (VOID-HF) | Biotech Hunter | Biotech Hunter